Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PINNACLE 3: Safety Extension of Bevespi Aerosphere in COPD
NCT01970878Phase 3Completed
- Sponsor
- Pearl Therapeutics
- Start
- Nov 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of BEVESPI AEROSPHERE in chronic obstructive pulmonary disease (COPD), sponsored by Pearl Therapeutics. Started Nov 2013; status: completed.
02
Drugs
BEVESPI AEROSPHERE
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01970878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01970878.